These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 9114949

  • 21. Case report of a toxic reaction from a combination of tryptophan and phenelzine.
    Thomas JM, Rubin EH.
    Am J Psychiatry; 1984 Feb; 141(2):281-3. PubMed ID: 6691495
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
    Kahn D, Silver JM, Opler LA.
    J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181
    [Abstract] [Full Text] [Related]

  • 24. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA.
    Ned Tijdschr Geneeskd; 2003 Oct 04; 147(40):1940-3. PubMed ID: 14574774
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Use of MAOI antidepressants.
    Ravaris CL, Robinson DS, Nies A, Ives JO, Bartlett D.
    Am Fam Physician; 1978 Jul 04; 18(1):105-11. PubMed ID: 665471
    [Abstract] [Full Text] [Related]

  • 27. CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression.
    Fawcett J, Kravitz HM, Zajecka JM, Schaff MR.
    J Clin Psychopharmacol; 1991 Apr 04; 11(2):127-32. PubMed ID: 2056139
    [Abstract] [Full Text] [Related]

  • 28. Patient compliance with MAO inhibitor therapy.
    Walker JI, Davidson J, Zung WW.
    J Clin Psychiatry; 1984 Jul 04; 45(7 Pt 2):78-80. PubMed ID: 6735998
    [Abstract] [Full Text] [Related]

  • 29. Combining stimulants with monoamine oxidase inhibitors: a review of uses and one possible additional indication.
    Feinberg SS.
    J Clin Psychiatry; 2004 Nov 04; 65(11):1520-4. PubMed ID: 15554766
    [Abstract] [Full Text] [Related]

  • 30. A clinical overview of monoamine oxidase inhibitors.
    Zisook S.
    Psychosomatics; 1985 Mar 04; 26(3):240-6, 251. PubMed ID: 3887453
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults.
    Shulman KI, Fischer HD, Herrmann N, Huo CY, Anderson GM, Rochon PA.
    J Clin Psychiatry; 2009 Dec 04; 70(12):1681-6. PubMed ID: 19852903
    [Abstract] [Full Text] [Related]

  • 36. Central nervous system toxicity after abrupt monoamine oxidase inhibitor switch: a case report.
    Safferman AZ, Masiar SJ.
    Ann Pharmacother; 1992 Mar 04; 26(3):337-8. PubMed ID: 1554951
    [Abstract] [Full Text] [Related]

  • 37. Adverse consequences of fluoxetine-MAOI combination therapy.
    Feighner JP, Boyer WF, Tyler DL, Neborsky RJ.
    J Clin Psychiatry; 1990 Jun 04; 51(6):222-5. PubMed ID: 2347858
    [Abstract] [Full Text] [Related]

  • 38. Monoamine oxidase-inhibiting antidepressants. A clinical update.
    Murphy DL, Sunderland T, Cohen RM.
    Psychiatr Clin North Am; 1984 Sep 04; 7(3):549-62. PubMed ID: 6384960
    [Abstract] [Full Text] [Related]

  • 39. Management of monoamine oxidase inhibitor-associated insomnia with trazodone.
    Nierenberg AA, Keck PE.
    J Clin Psychopharmacol; 1989 Feb 04; 9(1):42-5. PubMed ID: 2708555
    [Abstract] [Full Text] [Related]

  • 40. Monoamine oxidase inhibitors: safety and efficacy issues.
    Brown CS, Bryant SG.
    Drug Intell Clin Pharm; 1988 Mar 04; 22(3):232-5. PubMed ID: 3284731
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.